1-200900178-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001142569.3(INAVA):c.255C>T(p.Ile85=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00109 in 1,614,140 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0010 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 4 hom. )
Consequence
INAVA
NM_001142569.3 synonymous
NM_001142569.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.68
Genes affected
INAVA (HGNC:25599): (innate immunity activator) Involved in several processes, including nucleotide-binding activity oligomerization domain containing 2 signaling pathway; positive regulation of cytokine production; and positive regulation of intracellular signal transduction. Located in cytoplasm and nucleus. Implicated in inflammatory bowel disease 29. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 1-200900178-C-T is Benign according to our data. Variant chr1-200900178-C-T is described in ClinVar as [Benign]. Clinvar id is 781798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.68 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INAVA | NM_001142569.3 | c.255C>T | p.Ile85= | synonymous_variant | 4/10 | ENST00000413687.3 | NP_001136041.1 | |
INAVA | NM_018265.4 | c.510C>T | p.Ile170= | synonymous_variant | 4/10 | NP_060735.4 | ||
INAVA | NM_001367289.1 | c.255C>T | p.Ile85= | synonymous_variant | 4/10 | NP_001354218.1 | ||
INAVA | NM_001367290.1 | c.-281C>T | 5_prime_UTR_variant | 4/10 | NP_001354219.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INAVA | ENST00000413687.3 | c.255C>T | p.Ile85= | synonymous_variant | 4/10 | 2 | NM_001142569.3 | ENSP00000392105 | P2 | |
INAVA | ENST00000367342.8 | c.552C>T | p.Ile184= | synonymous_variant | 4/10 | 1 | ENSP00000356311 | A2 | ||
INAVA | ENST00000451872.6 | c.255C>T | p.Ile85= | synonymous_variant | 4/5 | 3 | ENSP00000397255 |
Frequencies
GnomAD3 genomes AF: 0.00104 AC: 158AN: 152222Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
158
AN:
152222
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00104 AC: 260AN: 251074Hom.: 0 AF XY: 0.00104 AC XY: 141AN XY: 135736
GnomAD3 exomes
AF:
AC:
260
AN:
251074
Hom.:
AF XY:
AC XY:
141
AN XY:
135736
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00109 AC: 1594AN: 1461800Hom.: 4 Cov.: 31 AF XY: 0.00112 AC XY: 816AN XY: 727212
GnomAD4 exome
AF:
AC:
1594
AN:
1461800
Hom.:
Cov.:
31
AF XY:
AC XY:
816
AN XY:
727212
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00104 AC: 158AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.00110 AC XY: 82AN XY: 74488
GnomAD4 genome
AF:
AC:
158
AN:
152340
Hom.:
Cov.:
33
AF XY:
AC XY:
82
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 26, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at